中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 7
Jul.  2014
Turn off MathJax
Article Contents

Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1

DOI: 10.3969/j.issn.1001-5256.2014.07.034
  • Received Date: 2013-09-09
  • Published Date: 2014-07-20
  • During the development and procession of liver fibrosis, peroxisome proliferator- activated receptor (PPAR) α and γ are in charge of the regulation of lipid metabolism, fatty acid metabolism, anti- liver fibrosis, etc., and are closely related to fat metabolism- related enzymes. As a key enzyme in fat metabolism, acyl- CoA synthetase long- chain family member 1 (ACSL1) is involved in lipid synthesis and catabolism and then causes lipid deposition and inflammation in the liver, so it directly or indirectly promotes hepatic fibrosis. The biological functions and roles of PPAR α and γ and ACSL1 are reviewed; the action mechanisms of PPAR α and γ in the transcriptional regulation of ACSL1 are briefly described; the regulatory effects of PPAR α and γ on ACSL1 and their effects on the progression of hepatic fibrosis are analyzed from the aspects of liver lipid metabolism and hepatic stellate cell activation. It is pointed out that in the liver PPAR α andγ are directly or indirectly involved in the progression of hepatic fibrosis by regulating ACSL1.

     

  • loading
  • [1]GONZALEZ FJ, SHAH YM.PPAR alpha:mechanism of species differences and hepatocarcino genesis of peroxisome proliferators[J].Toxicology, 2008, 246 (1) :2-8.
    [2]FILIP-CIUBOTARU F, FOIA L, MANCIUC C, et al.PPARs:structure, mechanisms of action and control.NoteI[J].Rev Med Chir Soc Med Nat Iasi, 2011, 115 (2) :477-484.
    [3]MANDRUP S, LANE MD.Regulating adipogenesis[J].J Biol Chem, 1997, 272:5367-5370.
    [4]MARCUS SL, MIYATA KS, ZHANG BW, et al.Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferatorresponsive elements of the rat hydratase/de-hydroganase and fatty acyl-CoA oxidase genes but diferentially induce expression[J].Proc Natl Acad Sci U S A, 1993, 90 (12) :5723-5727.
    [5]DREYER C, KREY G, KELLER H, et al.Control of the peroxisomeβoxidation pathway by a novel family of nuclear hormone receptors[J].Cell, 1992, 68 (5) :879-887.
    [6]BERGER J, MOLLER DE.The mechanisms of action of PPARs[J].Annu Rev Med, 2002, 53:409-435.
    [7]REDDY RC.Immunomodulatory role of PPAR-gamma in alveolar macrophages[J].J Investig Med, 2008, 56 (2) :522-527.
    [8]GHOSH AK, WEI J, WU MH, et al.Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator activated receptor-gamma[J].Biochem Biophys Res Commun, 2008, 374 (2) :231-236.
    [9]SOUPENE E, KUYPERS FA.Mammalian long-chain acyl-CoA synthetases[J].Exp Biol Med (Maywood) , 2008, 233 (5) :507-521.
    [10]LI LO, KLETT L, COLEMAN RA.Acyl-CoA synthesis, lipid metabolism and lipotoxicity[J].Biochim Biophys Acta, 2010, 1801 (3) :246-251.
    [11]LI LO, MASHEK DG, AN J, et al.Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes[J].J Biol Chem, 2006, 281 (48) :37246-37255.
    [12]MUOIO DM, LEWIN TM, WIEDMER P, et al.Acyl-CoAs are functionally channeled in liver:potential role of acyl-CoA synthetase[J].Am J Physiol Endocrinol Metab, 2000, 279 (6) :1366-1373.
    [13]FU M, ZHANG J, LIN Y, et al.Eady growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ/1 gene expression in human aortic smooth muscle cells[J].J Biol Chem, 2002, 277 (30) :26808-26814.
    [14]IP E, FARRELL GC, ROBERTSO G, et al.Central role of PPAR alpha dependent hepatic lipid turnover in dietary steatohepatitis in mice[J].Hepatology, 2003, 38 (1) :123-132.
    [15]REDDY JZ.Nonalcoholic steatosis and steatohepatitis.Ⅲ.Pemxisomal beta-oxidation, PPAR alpha, and steatohepatitis[J].Am J Physiol Gastmintest Liver Physiol, 2001, 281 (6) :1333-1339.
    [16]CARPINO G, MORIN S, GINANNI CORRADINI S, et al.Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurent chronic hepatitis after liver transplantation[J].Dig Liver Dis, 2005, 37 (5) :349-356.
    [17]UTO H, NAKANISHI L, IDO A, et al.The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet[J].Hepatol Res, 2005, 32 (4) :235-242.
    [18]LI LO, ELLIS M, HEATHER A, et al.Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis andβ-Oxidation and alters phospholipid fatty acid composition[J].J Biol Chem, 2009, 284 (41) :27816-27826.
    [19]LU LG, LI ZH.Recent research on liver fibrosis and cirrhosis[J].J Clin Hepatol, 2013, 29 (5) :321-323. (in Chinese) 陆伦根, 李郑红.肝纤维化及肝硬化近况研究[J].临床肝胆病杂志, 2013, 29 (5) :321-323.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2703) PDF downloads(558) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return